| abstract |
The present invention provides an essentially non-aqueous, liquid pharmaceutical concentrate composition for oral administration containing setralin or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides the use of this concentrated composition for preparing an aqueous solution of setraline. The present invention also provides a method of using this concentrated composition to treat or prevent various diseases or disorders. Finally, the present invention provides a compound, (1S-cis) -4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine methanesulfonate . |